Citizens Business Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,909
| Closed | -$284K | – | 137 |
|
|
2025
Q3 | $284K | Buy |
+2,909
| New | +$301K | 0.05% | 126 |
|
|
2022
Q3 | – | Sell |
-7,500
| Closed | -$280K | – | 140 |
|
|
2022
Q2 | $280K | Hold |
7,500
| – | – | 0.04% | 222 |
|
|
2022
Q1 | $332K | Hold |
7,500
| – | – | 0.04% | 222 |
|
|
2021
Q4 | $319K | Hold |
7,500
| – | – | 0.04% | 227 |
|
|
2021
Q3 | $325K | Hold |
7,500
| – | – | 0.04% | 216 |
|
|
2021
Q2 | $321K | Hold |
7,500
| – | – | 0.04% | 221 |
|
|
2021
Q1 | $290K | Hold |
7,500
| – | – | 0.04% | 222 |
|
|
2020
Q4 | $270K | Hold |
7,500
| – | – | 0.04% | 224 |
|
|
2020
Q3 | $287K | Hold |
7,500
| – | – | 0.05% | 202 |
|
|
2020
Q2 | $263K | Hold |
7,500
| – | – | 0.05% | 212 |
|
|
2020
Q1 | $245K | Hold |
7,500
| – | – | 0.05% | 213 |
|
|
2019
Q4 | $339K | Hold |
7,500
| – | – | 0.06% | 209 |
|
|
2019
Q3 | $305K | Hold |
7,500
| – | – | 0.05% | 218 |
|
|
2019
Q2 | $322K | Hold |
7,500
| – | – | 0.05% | 220 |
|
|
2019
Q1 | $288K | Hold |
7,500
| – | – | 0.05% | 223 |
|
|
2018
Q4 | $265K | Hold |
7,500
| – | – | 0.05% | 237 |
|
|
2018
Q3 | $289K | Sell |
7,500
-400
| -5% | -$14K | 0.05% | 244 |
|
|
2018
Q2 | $258K | Buy |
7,900
+400
| +5% | +$12.1K | 0.04% | 247 |
|
|
2018
Q1 | $205K | Buy |
+7,500
| New | +$204K | 0.04% | 251 |
|
|
2017
Q4 | – | Sell |
-7,500
| Closed | -$219K | – | 283 |
|
|
2017
Q3 | $219K | Hold |
7,500
| – | – | 0.04% | 265 |
|
|
2017
Q2 | $208K | Buy |
+7,500
| New | +$199K | 0.03% | 272 |
|
|
2016
Q3 | – | Sell |
-10,000
| Closed | -$234K | – | 273 |
|
|
2016
Q2 | $234K | Hold |
10,000
| – | – | 0.04% | 248 |
|
|
2016
Q1 | $188K | Hold |
10,000
| – | – | 0.04% | 259 |
|
|
2015
Q4 | $184K | Hold |
10,000
| – | – | 0.04% | 243 |
|
|
2015
Q3 | $164K | Sell |
10,000
-10,465
| -51% | -$179K | 0.03% | 257 |
|
|
2015
Q2 | $362K | Sell |
20,465
-7,035
| -26% | -$126K | 0.06% | 233 |
|
|
2015
Q1 | $488K | Hold |
27,500
| – | – | 0.09% | 211 |
|
|
2014
Q4 | $364K | Sell |
27,500
-17,500
| -39% | -$224K | 0.07% | 238 |
|
|
2014
Q3 | $531K | Sell |
45,000
-20,000
| -31% | -$252K | 0.1% | 211 |
|
|
2014
Q2 | $830K | Hold |
65,000
| – | – | 0.16% | 167 |
|
|
2014
Q1 | $879K | Hold |
65,000
| – | – | 0.17% | 164 |
|
|
2013
Q4 | $781K | Hold |
65,000
| – | – | 0.16% | 171 |
|
|
2013
Q3 | $763K | Hold |
65,000
| – | – | 0.16% | 157 |
|
|
2013
Q2 | $603K | Buy |
+65,000
| New | +$551K | 0.13% | 162 |
|
Other funds holding BSX
Citizens Business Bank's BSX Position: Q4 2025 in Review
Citizens Business Bank sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,909 shares — an estimated $284K sold.
Citizens Business Bank first reported a position in BSX in Q2 2013 and held it in 34 quarters. The position peaked at $879K in Q1 2014. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- Citizens Business Bank reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
- Citizens Business Bank sold 2,909 Boston Scientific shares in Q4 2025, an estimated $284K.
- Citizens Business Bank first reported a position in Boston Scientific in Q2 2013 and held it in 34 quarters.
- Citizens Business Bank's Boston Scientific position peaked at $879K in Q1 2014.
- 1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on Citizens Business Bank's 13F filing for Q4 2025, filed 2 Feb 2026.